Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v2-FR | |
---|---|---|
Language | English | French |
Date Updated | 2025-04-03 | 2024-11-25 |
Drug Identification Number | 02229048 | 02229048 |
Brand name | ISOVUE 370 INJECTION | ISOVUE 370 INJECTION |
Common or Proper name | IsoVue 370 | IsoVue 370 |
Company Name | BRACCO IMAGING CANADA | BRACCO IMAGING CANADA |
Ingredients | IOPAMIDOL | IOPAMIDOL |
Strength(s) | 76% | 76% |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | INTRAVASCULAR INTRAVASCULAR | INTRAVASCULAR INTRAVASCULAR |
Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
Additional packaging sizes | box of 10 vials of 100ml | box of 10 vials of 100ml |
ATC code | V08AB | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | 2024-11-27 | 2024-11-27 |
Actual start date | 2024-11-25 | 2024-11-25 |
Estimated end date | 2025-04-18 | 2024-12-15 |
Actual end date | 2025-04-04 | |
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Increase demand for this format due to supply chain issue for IsoVue 370 10X200ml and IsoVue 370 6 X 500ml impacted by the strike/lockout at port of Montreal | |
Health Canada comments |